TipRanks
pc:syn5v

Syneron Bio

Syneron Bio is a biotechnology company focused on the discovery and development of next-generation macrocyclic peptide therapeutics through its proprietary Synova™ platform. The company builds a robust pipeline targeting oncology and chronic diseases and leverages drug development expertise and data science to advance therapeutic candidates.

Leadership & Board

Current Number of Employees13
Current LinkedIn Followers430

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$250M
Total Amount Raised$250M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$150M
Latest Funding Amount$150M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

Syneron Bio had 13 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
13Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Syneron Bio had 430 followers as of September 14, 2026. The number of followers increased by 6 (1.42%) week-over-week.
430Latest Followers Count
6(1.42%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Apr 03, 2026
Series B
$150.00M
Dec 19, 2025
Series A
$100.00M

Investors

Similar Companies

A snapshot of private companies similar to Syneron Bio, helping you discover and navigate related company profiles.

Related News and Analysis